Safety
Ensures high safety by reducing Gadolinium deposition in the body
Registered
Active Ingredient ‘Gadoterate Meglumine’ registered with US FDA (#36148)
Approved
Approved for use in adults and paediatric population
Availability
Available in vials of 10ml, 15ml & 20ml
European regulatory authority has recommended the use of macrocyclic contrast agents & suspended / restricted use of linear contrast agents since 2017 due to safety concerns
| Product | Type | Recommendation |
|---|---|---|
| Gadobutrol | Macrocyclic | Maintain |
| Gadoterate | Macrocyclic | Maintain |
| Gadodiamide | Linear | Suspend |
| Gadobenate | Linear | Restrict use to liver scans |
| Gadopentetate | Linear | Restrict to intra-articular |
Source: https://www.ema.europa.eu/en/medicines/human/referrals/gadolinium-containing-contrast-agents
Vivere is a focused Contrast Media organization, bringing high quality, latest generation Contrast Agents to the diagnosis world
Vivere Imaging Pvt. Ltd.
H. No 13,14,15,16, Plot Nos. 14,15,16,
2nd & 3rd Floors,
Guttala Begumpet (v),
Serilingampally, RR Distict, 500 033,
Telangana, India
